42760-52-1Relevant academic research and scientific papers
Achieving Balanced Charge Transport and Favorable Blend Morphology in Non-Fullerene Solar Cells via Acceptor End Group Modification
Hao, Minghui,Liu, Tao,Xiao, Yiqun,Ma, Lik-Kuen,Zhang, Guangye,Zhong, Cheng,Chen, Zhanxiang,Luo, Zhenghui,Lu, Xinhui,Yan, He,Wang, Lei,Yang, Chuluo
, p. 1752 - 1760 (2019)
Generally, the electron-withdrawing substitution on the end-capping group of the acceptor-donor-acceptor type small-molecule acceptor (SMA) narrows the optical bandgap, and the electron-donating group lifts the lowest unoccupied molecular orbital (LUMO) e
HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS
-
Page/Page column 148; 278; 279, (2020/06/05)
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein R1, R2, R4, R5, R6, R7, R8, R9, R10,Z, X1, X2, X3, L2, HET, n and q are as defined herein. The compounds are inhibitors of adrenomedullin receptor subtype 2 (AM2). Also disclosed are the compounds for use in the treatment of diseases modulated AM2, including proliferative diseases such as cancer; pharmaceutical compositions comprising the compounds; methods for preparing the compounds; and intermediates useful in the preparation of the compounds.
Polysubstituted benzocyclopentadione derivative-based A-D-A conjugated molecule and application thereof
-
Paragraph 0078; 0080; 0081, (2019/06/13)
The invention discloses a polysubstituted benzocyclopentadione derivative-based A-D-A conjugated molecule and application thereof. The application chemical structural general formula of the conjugatedmolecule is as shown in the specification. According to
GASTIN AND CCK RECEPTOR LIGANDS
-
, (2008/06/13)
Compounds of formula (Ia), (Ib), or (Ic), wherein A represents a group having two fused rings, or a group of formula (Id), R 1 (m) represents up to 6 substituents, K represents--O--,--S--,--CH 2--,--N(R 2)--or--N(COR 2)--, in which R 2 is H or C 1 to C 3 alkyl, W is a carbonyl, sulfonyl or sulfinyl group, provided that at least one of W and X contains carbonyl, Y and Z are as given in the description, and their pharmaceutically acceptable salts are ligands at CCK and/or gastrin receptors. STR1
